Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing